psoriasis glp 1 and obesity are often clinically intertwined, and treatment strategies are evolving. This new ‘5in5’ digital microlearning breaks down the role of GLP-1 receptor agonists in psoriasis MAP Oily Stool Concerns on Flavor:Peach Mango

psoriasis glp 1 and obesity are often clinically intertwined, and treatment strategies are evolving. This new ‘5in5’ digital microlearning breaks down the role of GLP-1 receptor agonists in psoriasis MAP Oily Stool Concerns on Flavor:Peach Mango

Oily Stool Concerns on GLP-1 Medications

Every one percent decrease in body weight correlated directly with statistically significant improvements in the Disease Activity in Psoriatic Arthritis score

MAP

Flavor:Peach Mango

Industry developments include AbbVie’s USD2.23 billion deal with Gubra A/S to develop an amylin-targeting obesity drug, and Eli Lilly’s strategic price reduction for its weight-loss drug Zepbound to maintain market share